People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Other, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Evommune, Inc. | — | Other | Series D+ | $267.3M | $1.0B | 2020 |
| Avalo Therapeutics, Inc. | — | Biotechnology | Series D+ | $181.8M | $1.6B | 2016 |
| Dermira, Inc. | — | Other Health Care | Series C | $113.0M | $22.9M | 2011 |
Eugene Bauer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eugene Bauer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| EUGENE A. BAUER | 2 | 7 |
| David Cohen | 1 | 38 |
| Wende Hutton | 1 | 16 |
| Isaac Blech | 1 | 14 |
| Derek DiRocco | 1 | 7 |
| Sol J. Barer | 1 | 6 |
| Aaron Kantoff | 1 | 6 |
| Jake Nunn | 1 | 5 |
| Jake R. Nunn | 1 | 4 |
| David E. Cohen | 1 | 4 |
| Phil Gutry | 1 | 4 |
| Mark D. McDade | 1 | 3 |
| ULI HACKSELL | 1 | 3 |
| Behshad Sheldon | 1 | 3 |
| Magnus Persson | 1 | 3 |
| Thomas Wiggans | 1 | 3 |
| Fred B. Craves | 1 | 3 |
| Isaac A. Blech | 1 | 3 |
| Frank A. Torti | 1 | 3 |
| Christopher Sullivan | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.